China’s draft pharmaceutical trial rules aim to balance innovation with drug availability; CAC issues first rules to regulate ...

Cybersecurity Law amendment draft imposes heavier penalties. China proposes different data protection periods for three categories of drugs. Facial information collection requires obligations of ...

State Council restricts provision of evidence outside of mainland China for IP cases / CLP Reference: 5100/25.03.13 ; Promulgated: 2025-03-13 ; Effective: 2025-05-01 ...